DNA damage repair gene alteration status as a predictive marker for response to neoadjuvant chemotherapy in muscle invasive bladder cancer

by A. Bruchbacher, D. Ilijazi, M. Hassler, L. Müllauer, A. Haitel, P. Baltzer, I. Ertl, K. Gust, U. Lemberger, S. Shariat
Published 2020-07-01

First quarter report from the eBLOC (en-bloc vs conventional resection of primary bladder tumor) trial

by D. D’Andrea, F. Soria, K. Gust, P. Gontero, D. Enikeev, M. Taraktin, S. Kotov, M. Ryabov, L. Lusuardi, D. Oswald, R. Hurle, N. Frego, T. Wrba, S.F. Shahrokh
Published 2020-07-01